Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
The FDA and European Medicines Agency have reviewed available data and concluded that while pancreatitis should be considered a potential risk, the evidence does not support withdrawing these medications from the market
Dispose of used syringes in accordance with local regulations
Not recommended in pregnancy
In the SURMOUNT-OSA trial, tirzepatide reduced the apnea-hypopnea index by up to 62.8%, translating to approximately 30 fewer breathing interruptions per hour of sleep
It works in a unique way by mimicking the action of two hormones that are naturally present in the body, which helps control blood sugar levels and reduces appetite
Reconstitution Steps for Data Integrity
US$ 29.77
US$ 29.64
US$ 29.63
US$ 28.92
US$ 23.37
US$ 25.22
